CPHI Podcast Series: the power of digital marketing in pharma
.png)
Digital marketing is a valuable tool for many industries, and the pharmaceutical and healthcare industry is no exception. The CPHI Podcast Series covers how marketing can be used by companies to increase their engagement and overcome challenges.
Digital Editor Lucy Chard is joined by Raman Sehgal, Founder of Ramarketing, talking about the use of marketing in sustainability, talent acquisition, and partnering.
Having founded several niche companies, Raman has grown ramarketing (headquartered in the UK’s North East with a presence in Boston, MA) beyond what he ever could have imagined. A multi-million dollar, PE-backed, specialist marketing agency in the life science space across the world to raise their profile and grow.
Raman is the co-founder of Lead Candidate, a specialist talent acquisition partner for the pharma and biotech outsourcing space, and a fellow podcaster, hosting industry-leading pharmaceutical podcast - Molecule to Market where he takes listeners inside the outsourcing space of the drug development and manufacturing ecosystem.
Outside of work, Raman is family-oriented. He is a happily married father of three boisterous boys. An active and sociable guy, Raman is a keen runner and a die-hard Newcastle United football fan.
Keen to share his knowledge, mistakes, and learnings in an honest manner, Raman is focused on helping others and is an active member of the business community. One of his favorite mottos is “sharing is caring, right?”, which is reflected in the impact that his work has on other businesses and individuals alike.
In this podcast the different ways marketing can help companies in achieving their goals are discussed, whether it’s in how to go about finding the right partner, creating the right messaging around a companies’ ESG values, or how to attract talent. We also go on to talk about the future of digital marketing, especially the increased use of AI in today’s world, how much this has changed everyday practices already, and how important marketing is for accelerating innovation in the industry today.
See the full podcast episode here.
Related News
-
News Google-backed start-up raises US$600 million to support AI drug discovery and design
London-based Isomorphic Labs, an AI-driven drug design and development start-up backed by Google’s AI research lab DeepMind, has raised US$600 million in its first external funding round by Thrive Capital. The funding will provide further power t... -
News AstraZeneca to invest US$2.5 billion in Beijing R&D centre
Amid investigations of former AstraZeneca China head Leon Wang in 2024, AstraZeneca have outlined plans to establish its sixth global strategic R&D centre in China. Their aim is to further advance life sciences in China with major research and manufact... -
News Experimental drug for managing aortic valve stenosis shows promise
The new small molecule drug ataciguat is garnering attention for its potential to manage aortic valve stenosis, which may prevent the need for surgery and significantly improve patient experience.
-
News How GLP-1 agonists are reshaping drug delivery innovations
GLP-1 agonist drug products like Ozempic, Wegovy, and Mounjaro have taken the healthcare industry by storm in recent years. Originally conceived as treatment for Type 2 diabetes, the weight-loss effects of these products have taken on unprecedented int... -
News A Day in the Life of a Start-Up Founder and CEO
At CPHI we work to support Start-Up companies in the pharmaceutical industry and recognise the expertise and innovative angles they bring to the field. Through our Start-Up Programme we have gotten to know some of these leaders, and in this Day in the ... -
News Biopharmaceutical manufacturing boost part of new UK government budget
In their national budget announced by the UK Labour Party, biopharmaceutical production and manufacturing are set to receive a significant boost in capital grants through the Life Sciences Innovative Manufacturing Fund (LSIMF).
-
News CPHI Podcast Series: The power of proteins in antibody drug development
In the latest episode of the CPHI Podcast Series, Lucy Chard is joined by Thomas Cornell from Abzena to discuss protein engineering for drug design and development.
-
News Amgen sues Samsung biologics unit over biosimilar for bone disease
Samsung Bioepis, the biologics unit of Samsung, has been issued a lawsuit brought forth by Amgen over proposed biosimilars of Amgen’s bone drugs Prolia and Xgeva.